23.61
Surgery Partners Inc stock is traded at $23.61, with a volume of 2.23M.
It is up +3.55% in the last 24 hours and up +5.73% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$22.80
Open:
$22.68
24h Volume:
2.23M
Relative Volume:
2.11
Market Cap:
$3.03B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-87.44
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
+3.55%
1M Performance:
+5.73%
6M Performance:
-0.96%
1Y Performance:
-13.45%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SGRY
Surgery Partners Inc
|
23.61 | 2.92B | 2.89B | -33.80M | 204.10M | -0.27 |
![]()
HCA
Hca Healthcare Inc
|
381.39 | 90.60B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
THC
Tenet Healthcare Corp
|
168.77 | 15.14B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
EHC
Encompass Health Corp
|
120.90 | 11.98B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
190.35 | 12.00B | 16.08B | 1.20B | 1.06B | 17.82 |
![]()
DVA
Davita Inc
|
136.26 | 10.44B | 12.82B | 936.34M | 1.47B | 10.74 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-16-24 | Initiated | BofA Securities | Buy |
Oct-14-24 | Initiated | UBS | Buy |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-28-24 | Initiated | Macquarie | Outperform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
May-12-23 | Initiated | Mizuho | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-10-22 | Resumed | Citigroup | Buy |
Nov-30-21 | Initiated | Barclays | Overweight |
Nov-29-21 | Upgrade | Stifel | Hold → Buy |
Nov-01-21 | Initiated | JP Morgan | Neutral |
Oct-18-21 | Initiated | SVB Leerink | Outperform |
Sep-10-21 | Initiated | Cowen | Market Perform |
Jun-23-21 | Resumed | Stifel | Hold |
Sep-17-20 | Reiterated | The Benchmark Company | Buy |
Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
Jan-14-20 | Reiterated | The Benchmark Company | Buy |
Nov-16-18 | Initiated | UBS | Neutral |
Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-28-18 | Upgrade | Stifel | Sell → Hold |
Jan-30-18 | Reiterated | The Benchmark Company | Buy |
Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
Aug-09-17 | Downgrade | Stifel | Hold → Sell |
Apr-24-17 | Reiterated | Stifel | Hold |
Mar-10-17 | Downgrade | Stifel | Buy → Hold |
Jan-31-17 | Initiated | The Benchmark Company | Buy |
Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
Oct-27-15 | Initiated | Stifel | Buy |
Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Surgery Partners Inc (SGRY) Trading 4.94% Higher on May 30 - GuruFocus
Cantor Fitzgerald maintains Overweight on Surgery Partners shares By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Surgery Partners shares - Investing.com
Assessing Surgery Partners: Insights From 4 Financial Analysts - Benzinga
Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT - MSN
Surgery Partners (SGRY) Target Price Lowered by Barclays | SGRY Stock News - GuruFocus
Surgery Partners price target lowered to $24 from $25 at Barclays - TipRanks
Surgery Partners (SGRY) Faces Price Target Reduction by Barclays | SGRY Stock News - GuruFocus
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Q1 Earnings Highlights: Surgery Partners (NASDAQ:SGRY) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
Surgery Partners gains amid report of AMSURG sale process - MSN
Surgery Partners (SGRY) Shares Climb Amid AMSURG Sale Speculatio - GuruFocus
Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth - MSN
Surgery Partners stock gains amid report of AMSURG sale process - Seeking Alpha
Decoding Surgery Partners Inc (SGRY): A Strategic SWOT Insight - GuruFocus
Commit To Purchase Surgery Partners At $20, Earn 30.4% Annualized Using Options - Nasdaq
Investor Network: Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Northern Trust Corp Acquires 15,657 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
The Manufacturers Life Insurance Company Decreases Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners stock holds Buy rating, $35 target from Benchmark By Investing.com - Investing.com Canada
Leerink cuts Surgery Partners target to $34, keeps Outperform rating By Investing.com - Investing.com Nigeria
Leerink cuts Surgery Partners target to $34, keeps Outperform rating - Investing.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Call Transcript - Insider Monkey
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: St - GuruFocus
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Surgery Partners (SGRY) Misses Q1 Earnings Expectations - GuruFocus
Surgery Partners (SGRY) Reports Q1 2025 Growth in Revenue and Su - GuruFocus
Surgery Partners Reports Q1 Revenue Growth and Reaffirms 2025 Outlook - TipRanks
Surgery Partners Inc. Reports Strong Growth Amid Challenges - TipRanks
Surgery Partners Inc Reports Q1 2025 Results: EPS Misses at -$0. - GuruFocus
Surgery Partners: Q1 Earnings Snapshot - MySA
Surgery Partners Misses Q1 Marks But Sticks To 2025 OutlookSurgery Partners (NASDAQ:SGRY) - Benzinga
Surgery Partners Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Earnings call transcript: Surgery Partners Q1 2025 results show mixed performance - Investing.com
Surgery Partners Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Surgery Partners Reaffirms FY25 OutlookUpdate - Nasdaq
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates - Yahoo Finance
Surgery Partners, Inc. Announces First Quarter 2025 Results; Rea - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Perfor - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Performance | SGRY Stock News - GuruFocus
Why Surgery Partners Stock is Under Pressure - TipRanks
(SGRY) Surgery Partners Expects 2025 Revenue Range $3.3B$3.45B, vs. FactSet Est of $3.39B - marketscreener.com
Earnings Flash (SGRY) Surgery Partners Posts Q1 Revenue $776M, vs. FactSet Est of $777.3M - marketscreener.com
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance - The Manila Times
Surgery Partners (NASDAQ:SGRY) Posts Q1 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):